[Effect of L-tetramisol associated with rifampicin in patients with lepromatous leprosy. L-tetramisol in patients with lepromatous leprosy].
In this work are presented results obtained in the treament of thirty patients suffering of lepromatous leprosy. In a group of fifteen patients L-tetramisol was administrated in association to antimocrobian drugs. The control group received only the last medication. Immunological modifications were not observed in any case. However, in six patients treated with L-tetramisol associated to rifampicin during three months it was possible to observe a notable improvement of the clinical state. In the patients that received L-tetramisol associated to other drugs or in those that received only antimicrobian drugs the clinical improvement was very low or null.
D000293:Adolescent; D000328:Adult; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D013773:Tetramisole / Q000627:therapeutic use*
D013773:Tetramisole; D012293:Rifampin
Acción del L-tetramisol asociado a la rifampicina en pacientes con lepra lepromatosa. L-tetramisol en pacientes con lepra lepromatosa.